FINDING NEW AVENUES TO OVERCOME CHEMORESISTANCE FOR IMPROVED CANCER THERAPY
FINDING NEW AVENUES TO OVERCOME CHEMORESISTANCE FOR IMPROVED CANCER THERAPY
批准号:
nhmrc : GNT1156095
负责人:
A/Pr Marco Herold
金额:
$64.92万
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For many patients with cancer, the best hope for obtaining cures or much longer remission lies in new drugs that efficiently kill the tumour cells by targeting cell survival pathways or by somehow reinstalling chemotherapeutic response. We aim to develop novel small molecules able to neutralise pro-survival proteins. Furthermore, we aim to identify new tumour suppressor genes, some of which are likely to represent attractive targets for cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The mutagenic influence of 5-methylcytosine and its relevance for cancer treatment
-
批准号:nhmrc : 1145912
-
项目类别:Project Grants
-
资助金额:$57.1万
-
财政年份:2018
-
负责人:A/Pr Marco Herold
-
依托单位:
Elucidating the cellular processes that are critical for p53 mediated tumour suppression
-
批准号:nhmrc : GNT1143105
-
项目类别:Project Grants
-
资助金额:$101.61万
-
财政年份:2018
-
负责人:A/Pr Marco Herold
-
依托单位:
Elucidating the cellular processes that are critical for p53 mediated tumour suppression
-
批准号:nhmrc : 1143105
-
项目类别:Project Grants
-
资助金额:$68.7万
-
财政年份:2018
-
负责人:A/Pr Marco Herold
-
依托单位:
The mutagenic influence of 5-methylcytosine and its relevance for cancer treatment
-
批准号:nhmrc : GNT1145912
-
项目类别:Project Grants
-
资助金额:$84.45万
-
财政年份:2018
-
负责人:A/Pr Marco Herold
-
依托单位:
The role of the pro-survival Bcl-2 family member A1 in the development and sustained growth of lymphomas.
-
批准号:nhmrc : 1049720
-
项目类别:Project Grants
-
资助金额:$41.91万
-
财政年份:2013
-
负责人:A/Pr Marco Herold
-
依托单位:
海外基金